Mark Moore
5Patents
3h-index
9Co-inventors
50Inventor score
Filing activity: Jan 13, 1992 → May 12, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6248724A | Antisense oligonucleotide compositions targeted to angiotensin converting enzyme MRNA and methods of use | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6909031B2 | Transgenic mice containing glucagon receptor gene disruptions | Chemistry; Metallurgy | 11 | Expired |
| US5352608A | Bioreduction of metal oxides and oxyanions by photosynthetic bacteria | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5804424A | Process for the production of hydrogen using photosynthetic proteobacteria | Emerging Cross-Sectional Technologies | 3 | Expired |
| US12188018B2 | Polypeptides useful for gene editing and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.